Free Practice Questions for Kuwait Board Internal Medicine

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Kuwait Board Specialty Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Sample Kuwait Board Internal Medicine Practice Questions

Try these sample questions to review concepts for the Kuwait Board Internal Medicine exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 58-year-old man presents to a rural emergency department in Kuwait with 75 minutes of severe retrosternal chest pain radiating to his left shoulder and diaphoresis. An electrocardiogram demonstrates 3-mm ST-segment elevation in leads V1 through V4 with reciprocal ST depressions in leads II, III, and aVF. The nearest hospital with a 24-hour cardiac catheterization laboratory is 85 km away, with an estimated transfer time and door-to-balloon time of 140 minutes. He has no contraindications to thrombolysis. What is the most appropriate reperfusion strategy?

A.Administer intravenous unfractionated heparin and aspirin, and observe until elective catheterization

B.Transfer immediately for primary percutaneous coronary intervention without fibrinolysis

C.Administer weight-adjusted intravenous tenecteplase immediately, followed by routine transfer for coronary angiography

D.Perform emergency bedside pericardiocentesis before arranging transport

Explanation: According to international guidelines for ST-segment elevation myocardial infarction (STEMI), when primary percutaneous coronary intervention (PCI) cannot be delivered within 120 minutes of first medical contact, immediate fibrinolytic therapy (preferably with a fibrin-specific agent such as tenecteplase) should be administered within 30 minutes of arrival, followed by transfer to a PCI-capable center for rescue or routine post-fibrinolysis catheterization.

2A 66-year-old woman with chronic heart failure with reduced ejection fraction (HFrEF, left ventricular ejection fraction 30%) returns for outpatient clinic evaluation. She is currently asymptomatic (NYHA Class I) on bisoprolol 5 mg daily and enalapril 10 mg twice daily. Physical examination reveals a blood pressure of 122/74 mmHg, pulse of 64 bpm, clear lung fields, and no peripheral edema. Laboratory evaluation shows serum creatinine of 92 μmol/L and serum potassium of 4.3 mmol/L. Which of the following therapeutic adjustments provides the greatest additional reduction in all-cause mortality?

A.Switch enalapril to sacubitril/valsartan (after a 36-hour washout), and initiate spironolactone and dapagliflozin

B.Increase enalapril to 20 mg twice daily and maintain current therapy

C.Add ivabradine 5 mg twice daily to further reduce myocardial oxygen demand

D.Initiate digoxin 0.125 mg daily to enhance inotropic support

Explanation: Guideline-directed medical therapy (GDMT) for HFrEF incorporates four foundational drug classes with proven mortality reduction: an angiotensin receptor-neprilysin inhibitor (ARNI, preferred over ACE inhibitors after a 36-hour washout), an evidence-based beta-blocker, a mineralocorticoid receptor antagonist (MRA, e.g. spironolactone), and an SGLT2 inhibitor (e.g. dapagliflozin or empagliflozin). Titrating up to quadruple therapy is recommended even in asymptomatic or mildly symptomatic patients.

3A 72-year-old man with hypertension, type 2 diabetes mellitus, and a prior ischemic stroke 3 years ago is found to have asymptomatic atrial fibrillation during a routine clinic visit. His blood pressure is 134/82 mmHg, heart rate is 88 bpm and irregularly irregular. Laboratory testing reveals serum creatinine of 110 μmol/L with an estimated GFR of 62 mL/min/1.73 m². Echocardiography shows mild left atrial enlargement and normal ventricular function. What is the most appropriate antithrombotic management for stroke prevention?

A.Aspirin 81 mg daily combined with clopidogrel 75 mg daily

B.Oral apixaban 5 mg twice daily

C.Oral warfarin targeting an INR of 1.5 to 2.0

D.Aspirin 325 mg monotherapy daily

Explanation: This patient has a CHA2DS2-VASc score of 5 (Age >=75 is 2, but he is 72 [1 point], Diabetes [1], Hypertension [1], Prior stroke/TIA [2 points] = 5 points), representing a high risk of thromboembolic stroke. In non-valvular atrial fibrillation with an elevated stroke risk, direct oral anticoagulants (DOACs) such as apixaban are preferred over warfarin due to superior or non-inferior efficacy and lower rates of intracranial hemorrhage. Full-dose apixaban (5 mg twice daily) is appropriate because he meets none of the three dose-reduction criteria (age >=80 years, weight <=60 kg, creatinine >=133 μmol/L); dose reduction to 2.5 mg twice daily requires at least two of them.

4A 54-year-old man presents to the emergency department with tearing anterior chest pain radiating straight through to his back between the scapulae that began abruptly 45 minutes ago. Physical examination reveals an anxious, diaphoretic patient. Blood pressure is 196/112 mmHg in the right arm and 168/94 mmHg in the left arm. Heart rate is 96 bpm. A soft, early diastolic murmur is audible at the right upper sternal border. Urgent contrast-enhanced CT of the chest demonstrates an intimal flap extending from the ascending aorta into the aortic arch. Which of the following is the most appropriate initial pharmacological goal prior to urgent surgical intervention?

A.Intravenous unfractionated heparin bolus to prevent extension of false lumen thrombosis

B.Intravenous hydralazine boluses to lower systolic blood pressure below 140 mmHg

C.Intravenous nitroprusside monotherapy to rapidly normalize mean arterial pressure

D.Intravenous esmolol or labetalol to achieve a heart rate < 60 bpm and systolic blood pressure < 120 mmHg

Explanation: Acute Stanford Type A aortic dissection is a surgical emergency. The immediate medical objective is anti-impulse therapy: reducing aortic shear stress (dP/dt) and blood pressure. Intravenous beta-blockers (such as esmolol or labetalol) are first-line to lower heart rate below 60 bpm, followed if necessary by vasodilators to achieve a systolic blood pressure between 100 and 120 mmHg. Beta-blockade must always precede vasodilator administration to prevent reflex tachycardia.

5A 28-year-old man presents with sharp retrosternal chest pain that worsened over the past 24 hours. The pain is aggravated by inspiration and coughing, and is distinctly relieved by sitting upright and leaning forward. He reports an upper respiratory tract viral infection 10 days ago. Vital signs show blood pressure of 124/78 mmHg, heart rate of 88 bpm, respiratory rate of 16 breaths/min, and temperature of 37.6 °C. A triphasic friction rub is audible at the lower left sternal border. Electrocardiogram reveals diffuse concave-upward ST-segment elevation with PR-segment depression in limb and precordial leads, and reciprocal PR elevation in lead aVR. What is the first-line treatment regimen for this patient?

A.High-dose ibuprofen (600–800 mg every 8 hours) plus oral colchicine (0.5 mg daily)

B.Oral prednisone (1 mg/kg daily) monotherapy for 4 weeks

C.Oral broad-spectrum moxifloxacin for 10 days

D.Sublingual nitroglycerin as needed plus low-dose aspirin (81 mg daily)

Explanation: This patient has acute idiopathic or viral pericarditis. First-line therapy consists of a nonsteroidal anti-inflammatory drug (such as ibuprofen 600–800 mg every 8 hours or aspirin 750–1000 mg every 8 hours) combined with oral colchicine (0.5–0.6 mg daily for 3 months). Colchicine significantly accelerates symptom resolution and reduces the rate of recurrent pericarditis by approximately 50%.

6A 78-year-old man presents with exertional lightheadedness and an episode of near-syncope while walking up stairs. Physical examination reveals a delayed and diminished carotid pulse (pulsus parvus et tardus) and a harsh crescendo-decrescendo systolic ejection murmur heard loudest at the second right intercostal space with radiation to both carotid arteries. Transthoracic echocardiogram demonstrates a heavily calcified trileaflet aortic valve with a peak jet velocity of 4.5 m/s, mean transvalvular gradient of 48 mmHg, and calculated aortic valve area of 0.7 cm². Left ventricular ejection fraction is 55%. What is the most definitive next step in management?

A.Percutaneous balloon aortic valvuloplasty as definitive curative therapy

B.Initiation of high-dose ACE inhibitor therapy and follow-up in 6 months

C.Prompt aortic valve replacement (surgical AVR or transcatheter TAVR)

D.Exercise treadmill testing to objectively quantify functional capacity

Explanation: This patient has severe symptomatic aortic stenosis (aortic valve area < 1.0 cm², peak velocity > 4.0 m/s, mean gradient > 40 mmHg, presenting with exertional syncope/presyncope). Once symptoms develop in severe aortic stenosis, mortality increases dramatically (approximately 50% at 2-3 years without intervention). Prompt aortic valve replacement (surgical AVR or transcatheter aortic valve implantation/TAVR based on heart team assessment and patient risk profile) is the definitive class I indication.

7A 56-year-old male executive presents for evaluation of reproducible retrosternal chest tightness that occurs after walking briskly for 10 minutes and completely subsides within 3 minutes of resting. He has hypertension treated with amlodipine 5 mg daily. Blood pressure is 138/84 mmHg and resting heart rate is 82 bpm. Baseline ECG is normal. An exercise stress test reproduces his typical chest discomfort along with 1.5-mm horizontal ST-segment depressions in leads V4-V6. What is the recommended first-line antianginal pharmacotherapy to relieve symptoms and prevent myocardial ischemia?

A.Long-acting oral isosorbide mononitrate monotherapy

B.Oral cardioselective beta-blocker (e.g. metoprolol succinate or bisoprolol)

C.Oral ranolazine monotherapy

D.Oral dipyridamole therapy

Explanation: For patients with chronic stable angina pectoris, cardioselective beta-blockers (such as metoprolol succinate, bisoprolol, or atenolol) are the recommended first-line antianginal therapy. They decrease myocardial oxygen demand by reducing resting and exercise heart rate, blood pressure, and myocardial contractility, and they possess proven secondary prevention benefits in coronary disease.

8A 62-year-old man is hospitalized with a 3-week history of low-grade fever, anorexia, night sweats, and a new regurgitant heart murmur. Transthoracic echocardiogram reveals a 9-mm oscillating vegetation on the posterior mitral leaflet with moderate mitral regurgitation. Three sets of blood cultures drawn 1 hour apart grow Streptococcus gallolyticus (formerly Streptococcus bovis). Which of the following additional investigations is mandatory in this patient?

A.Endoscopic retrograde cholangiopancreatography (ERCP)

B.Bone marrow biopsy

C.Computed tomography of the sinuses

D.Complete colonoscopy

Explanation: Streptococcus gallolyticus (Streptococcus bovis biotype I) bacteremia and infective endocarditis have a strong, well-established association with gastrointestinal neoplasia, particularly colorectal adenocarcinoma and premalignant adenomatous polyps (present in up to 60% of patients). Even in the absence of GI symptoms, a complete colonoscopy is mandatory during or immediately following hospitalization.

9A 32-year-old male athlete undergoes cardiovascular evaluation after experiencing exertional chest discomfort and lightheadedness. His father died suddenly at age 38. Cardiac auscultation reveals a harsh crescendo-decrescendo systolic murmur at the lower left sternal border that increases in intensity during the strain phase of the Valsalva maneuver and decreases during passive leg raise. Echocardiography demonstrates asymmetric septal hypertrophy (interventricular septum 22 mm, posterior wall 11 mm) with systolic anterior motion of the mitral valve and an elevated left ventricular outflow tract (LVOT) gradient of 52 mmHg at rest. Which medication is most appropriate as initial medical therapy?

A.Oral isosorbide dinitrate

B.Oral amlodipine

C.Oral bisoprolol or metoprolol

D.Oral hydrochlorothiazide

Explanation: This patient has hypertrophic cardiomyopathy (HCM) with dynamic LVOT obstruction. The murmur increases with maneuvers that decrease LV preload (Valsalva, standing) and decreases with maneuvers that increase preload (squatting, passive leg raise). Non-vasodilating beta-blockers (e.g. metoprolol, bisoprolol) or non-dihydropyridine CCBs (verapamil) are first-line pharmacotherapy; they prolong diastole, increase ventricular filling, and decrease inotropy, thereby reducing the outflow tract gradient and alleviating symptoms.

10A 45-year-old woman with metastatic breast cancer presents with progressive dyspnea, orthopnea, and profound fatigue. On physical examination, blood pressure is 88/64 mmHg with a pulsus paradoxus of 18 mmHg. Heart rate is 118 bpm. The jugular venous pulse is elevated to the angle of the jaw, and heart sounds are markedly muffled. Electrocardiogram reveals sinus tachycardia with low QRS voltage and beat-to-beat variation in QRS amplitude across precordial leads. What is the definitive emergency intervention of choice?

A.Emergency ultrasound-guided pericardiocentesis

B.Intravenous furosemide 40 mg bolus

C.Urgent needle thoracostomy in the second intercostal space

D.Intravenous metoprolol 5 mg slow bolus

Explanation: This patient exhibits the classic features of cardiac tamponade: Beck's triad (hypotension, elevated jugular venous pressure, muffled heart sounds), severe pulsus paradoxus (> 10 mmHg drop in SBP on inspiration), and electrical alternans on ECG due to the heart swinging within a massive pericardial effusion. Emergency pericardiocentesis (preferably under echocardiographic guidance) is the life-saving procedure of choice to relieve intrapericardial pressure and restore venous return and cardiac output.

About the Kuwait Board Internal Medicine Exam

Summative written examinations of the Kuwaiti Board of Internal Medicine (KBIM) residency programme, run under the KIMS Examinations Office. The Part 2 final exam is developed and administered by a committee reporting directly to the KIMS Exam Office rather than to the KBIM programme. This OpenExamPrep bank is independent English-language MCQ practice built to the published R1/Part 1 blueprint; it is not an official KIMS paper and does not simulate the OSCE component of the Part 2 exam.

Exam sponsor: Kuwait Institute for Medical Specialization (KIMS) Examinations Office. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

Three summative exams: an R1 written MCQ exam, the Part 1 (in-training) written MCQ exam, and the Part 2 final exam, which combines an MCQ component with an OSCE. The R1 and Part 1 papers cover the same 17 published disciplines, with Part 1 written at a higher level of difficulty.

Time Limit

Not published

Passing Score

Not published by KIMS. Under the KIMS Examinations Policies and Procedures (s15.3-15.4), each residency program sets its own marking system and standard setting using its psychometric approach, and all results are approved by the KIMS Secretary General.

Exam / Certification Fees

Not published

Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Official sources

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

20%

Cardiovascular & Respiratory Medicine

Coronary artery disease, heart failure, arrhythmias, valvular disorders, COPD, asthma, interstitial lung diseases, and ARDS.

18%

Neurology & Nephrology

Stroke syndromes, epilepsy, demyelinating disease, acute kidney injury, chronic kidney disease, and glomerulonephritis.

16%

Gastroenterology & Rheumatology

Cirrhosis, gastrointestinal bleeding, IBD, pancreatitis, rheumatoid arthritis, SLE, vasculitis, and crystal arthropathies.

Endocrinology, Diabetes & Metabolism

Type 1 and type 2 diabetes management, thyroid disorders, adrenal insufficiency, and calcium homeostasis.

Hematology & Medical Oncology

Anemias, thrombocytopenia, coagulopathies, hematologic malignancies, solid tumors, and oncologic emergencies.

11%

Infectious Diseases & Critical Care / ER / Toxicology

Community and hospital-acquired infections, sepsis bundles, tuberculosis, toxicology, and acute overdose management.

11%

Dermatology, Ophthalmology & Basic Science / Pharmacology

Cutaneous drug reactions, inflammatory eye disease, clinical pharmacokinetics, drug interactions, and antimicrobial mechanisms.

Geriatrics, Psychiatry & General Internal Medicine (High Value Care)

Delirium, dementia, depressive disorders, perioperative evaluation, preventive care, and high-value clinical stewardship.

Preparing for the Kuwait Board Internal Medicine Exam

What You Need to Know

Passing score: Not published by KIMS. Under the KIMS Examinations Policies and Procedures (s15.3-15.4), each residency program sets its own marking system and standard setting using its psychometric approach, and all results are approved by the KIMS Secretary General.
Assessment: Three summative exams: an R1 written MCQ exam, the Part 1 (in-training) written MCQ exam, and the Part 2 final exam, which combines an MCQ component with an OSCE. The R1 and Part 1 papers cover the same 17 published disciplines, with Part 1 written at a higher level of difficulty.
Time limit: Not published
Exam / certification fees: Not published Official sources

Using Our Practice Resources

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Frequently Asked Questions

What is the structure of the Kuwait Board Internal Medicine examinations?

The KBIM programme uses three summative exams. The R1 exam and the Part 1 (in-training) exam are written multiple-choice papers covering the same 17 published clinical disciplines, with Part 1 set at a higher level of difficulty. The Part 2 final exam combines an MCQ component with an OSCE.

Who administers the Kuwait Board Internal Medicine examination?

KBIM sits under the Kuwait Institute for Medical Specialization (KIMS). The Part 2 final exam is developed and administered by an independent committee that reports directly to the KIMS Examinations Office rather than to the KBIM programme.

What are the eligibility requirements for the KBIM Part 1 and Part 2 examinations?

KBIM requires a minimum of 21 months of residency training to sit the Part 1 exam, and a minimum of 52 months to sit the Part 2 final exam. Residents have three attempts at Part 1 and cannot progress to R4 without passing it.

What language are the KIMS examinations delivered in?

The KIMS Examinations Policies and Procedures state that KIMS examinations are offered in English, and that candidates must have reasonable written and oral fluency in English. The policy also allows a Program Examinations Committee to assess particular competencies in Arabic.

Is this practice bank an official KBIM exam?

No. This is independent English-language multiple-choice practice by OpenExamPrep, written to the discipline distribution that KBIM publishes for its R1 and Part 1 papers. It is a study aid, not an official KIMS paper, and it does not reproduce or simulate the OSCE component of the Part 2 final exam. KIMS does not publish the duration, fee, or pass mark for these exams.